Blueprint Medicines Corporation Stock Forecast

NASDAQ:BPMC Open Broker Account

$48.01 (0.81%)

Volume: 347.142k

Closed: Dec 02, 2022

Hollow Logo Score: 0.000

Blueprint Medicines Corporation Stock Forecast

$48.01 (0.81%)

Volume: 347.142k

Closed: Dec 02, 2022

Score Hollow Logo 0.000

Blueprint Medicines Corporation Stock Statistics NASDAQ:BPMC

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-11-28 - 2022-12-02 HOLD 6.39
2022-11-25 - 2022-11-28 SELL 0.512
2022-11-23 - 2022-11-25 HOLD 0.504
2022-10-18 - 2022-11-23 SELL -14.55
2022-10-17 - 2022-10-18 HOLD -2.86

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT